Research at Amavita
At Amavita, advancing cardiovascular care through clinical research is a core part of our mission. Our participation in groundbreaking clinical trials helps deliver tomorrow's treatments to our patients today.
Advancing Cardiovascular
Medicine
Our active clinical trials run through Amavita Research Services, affiliated with Amavita Heart and Vascular Health. With the help of our sponsors and patients, our team of clinical research professionals work to discover new concepts, develop ideas, and explore findings.
Featured Clinical Studies
Heart Failure Research
Dr. Pedro Martinez-Clark has served as principal investigator for several significant heart failure studies, including:
CYCLE Clinical Trials
Phase 2 studies evaluating the effectiveness of Tovinontrine in patients with both reduced and preserved ejection fraction heart failure. These randomized, double-blind, placebo-controlled trials are exploring new treatment options for patients with different types of heart failure.
CHAMP-HF Registry
An observational registry of treatment patterns in US heart failure patients with reduced ejection fraction, gathering valuable data on real-world outcomes to improve heart failure management strategies.
Vascular Innovations
The GREAT Trial
Testing the Golazo® Peripheral Atherectomy System for safe and effective treatment of peripheral artery disease, offering new options for patients with blocked leg arteries.
Pathfinder I
A post-market registry study of the AURYON Atherectomy Device in subjects with infrainguinal peripheral artery disease, evaluating real-world outcomes of this innovative technology.
Groundbreaking Valve Technologies
Percutaneous Mitral Valve Annuloplasty
Dr. Martinez-Clark served as Worldwide Principal Investigator for this groundbreaking trial testing the safety and efficacy of percutaneous mitral annuloplasty for patients with functional mitral regurgitation.
SPARE-MR
A feasibility study of spanning sutures for anterior-posterior reduction to eliminate mitral regurgitation in patients with heart failure, representing a significant advance in minimally invasive valve repair.
Participating in Clinical Research
Benefits for Patients
Participating in a clinical trial at Amavita offers several potential benefits:
Access to innovative treatments before they're widely available
Additional monitoring and care from our research team
Contributing to advancements that may help future patients with similar conditions
Current Enrollment Opportunities
We regularly enroll patients in new clinical trials for various cardiovascular conditions. Our research team can help determine if you might be eligible for any of our current studies.
The Importance of Research Leadership
Dr. Martinez-Clark's extensive involvement in clinical research—with participation in more than 25 trials throughout his career—directly benefits our patients in several ways:
Cutting-Edge Knowledge: Staying at the forefront of cardiovascular advances
Innovative Approaches: Developing new techniques based on latest research
Comprehensive Solutions: Access to experimental treatments for complex cases
Research participation is a key differentiator that sets Amavita apart from other cardiovascular practices. Our commitment to advancing medical knowledge ensures that our patients receive the most current, evidence-based care available.
Note: Participation in clinical trials is entirely voluntary. All studies undergo rigorous review to protect participant safety and are conducted following strict ethical guidelines.
Learn More About Our Research Programs
Stay connected with our ongoing research and clinical trials. Contact our dedicated research team to learn about current opportunities or to discuss how our research expertise can benefit your cardiovascular care.